Baseline severe anaemia should not preclude use of zidovudine in antiretroviral-eligible patients in resource-limited settings

BACKGROUND: Stavudine is no longer recommended as part of first-line therapy for patients initiating antiretroviral therapy (ART) in Uganda. Most patients are currently initiated on zidovudine-containing regimens, which can induce anaemia. We investigated the risk factors for early severe anaemia in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiragga, Agnes N, Castelnuovo, Barbara, Nakanjako, Damalie, Manabe, Yukari C
Formato: Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991285/
https://www.ncbi.nlm.nih.gov/pubmed/21047391
http://dx.doi.org/10.1186/1758-2652-13-42

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2991285/
https://www.ncbi.nlm.nih.gov/pubmed/21047391
http://dx.doi.org/10.1186/1758-2652-13-42

Ejemplares similares